These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2015169)

  • 1. The effects of flosequinan on regional blood flow in normal man.
    Scott RA; Woods KL; Barnett DB
    Br J Clin Pharmacol; 1991 Jan; 31(1):41-6. PubMed ID: 2015169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flosequinan does not affect systemic and regional vascular responses to simulated orthostatic stress in healthy volunteers.
    Duranteau J; Pussard E; Edouard A; Samii K; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1992 Sep; 34(3):207-14. PubMed ID: 1389945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of flosequinan and nifedipine on glucose tolerance in healthy volunteers.
    Lewis H; Kendall M; Bratty JR
    J Clin Pharm Ther; 1988 Aug; 13(4):269-72. PubMed ID: 3235476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and regional hemodynamic effects of flosequinan for congestive heart failure.
    Haas GJ; Binkley PF; Carpenter JA; Leier CV
    Am J Cardiol; 1989 Jun; 63(18):1354-9. PubMed ID: 2658526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of BTS 49465 on blood pressure and peripheral arteriolar and venous tone in normal volunteers.
    Cowley AJ; Wynne RD; Hampton JR
    J Hypertens Suppl; 1984 Dec; 2(3):S547-9. PubMed ID: 6599715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and neurohormonal effects of flosequinan in patients with heart failure.
    Isnard R; Lechat P; Pousset F; Carayon A; Kalotka H; Chikr H; Salloum J; Thomas D; Komajda M
    Fundam Clin Pharmacol; 1997; 11(1):83-9. PubMed ID: 9182081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of flosequinan, a new vasodilator, and propranolol on sub-maximal exercise in healthy volunteers.
    Lewis HM; Kendall MJ; Smith SR; Bratty JR
    Br J Clin Pharmacol; 1989 May; 27(5):547-52. PubMed ID: 2757879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers.
    Duranteau J; Pussard E; Berdeaux A; Giudicelli JF
    Br J Clin Pharmacol; 1995 Nov; 40(5):431-8. PubMed ID: 8703646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral labetalol on forearm and hepatic circulations in normotensive humans.
    Sweeney MO; Cinquegrani M; Liang CS
    J Lab Clin Med; 1987 May; 109(5):589-94. PubMed ID: 3572208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.
    Cowley AJ; Wynne RD; Stainer K; Fullwood L; Rowley JM; Hampton JR
    BMJ; 1988 Jul; 297(6642):169-73. PubMed ID: 3044507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the metabolic effects of flosequinan and propranolol in patients with non-insulin-dependent diabetes mellitus.
    Lewis HM; Kendall MJ; Wright AD; Bratty JR; Maxwell S
    J Clin Pharm Ther; 1991 Jun; 16(3):161-6. PubMed ID: 1869595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of concurrent administration of flosequinan and digoxin on the pharmacokinetics of each drug.
    Rau R; Hind ID; Wynne RD; White SA
    Arzneimittelforschung; 1994 Mar; 44(3):300-4. PubMed ID: 8192694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of flosequinan on autonomic tone in congestive heart failure: implications for the mechanism of the positive chronotropic effect and survival influence of long-term vasodilator administration.
    Binkley PF; Nunziata E; Cody RJ
    Am Heart J; 1994 Dec; 128(6 Pt 1):1147-56. PubMed ID: 7985595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men.
    Bengtsson-Hasselgren B; Rönn O; Blychert LO; Edgar B; Raner S
    Eur J Clin Pharmacol; 1990; 38(6):529-33. PubMed ID: 2373126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin differentially affects vascular blood flow in humans.
    Cook JS; Sauder CL; Ray CA
    Am J Physiol Heart Circ Physiol; 2011 Feb; 300(2):H670-4. PubMed ID: 21148765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of flosequinan on submaximal exercise in patients with chronic cardiac failure.
    Elborn JS; Riley M; Stanford CF; Nicholls DP
    Br J Clin Pharmacol; 1990 May; 29(5):519-24. PubMed ID: 2112405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats.
    Sim MF; Yates DB; Parkinson R; Cooling MJ
    Br J Pharmacol; 1988 Jun; 94(2):371-80. PubMed ID: 3293682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study of the effects of flosequinan on psychomotor function in healthy volunteers.
    King DJ; Bell P; Bratty JR; McEntegart DJ
    Int Clin Psychopharmacol; 1991; 6(3):155-68. PubMed ID: 1806622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of pharmacodynamic interactions between acute dose flosequinan and xamoterol. A pilot study in healthy subjects.
    Ng HW; Walley TJ; Tsao Y; Breckenridge AM
    Eur J Clin Pharmacol; 1994; 46(4):361-5. PubMed ID: 7957523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.